Resistant Hypertension in an Obese Patient With Obvious Obstructive Sleep Apnea and Occult Pheochromocytoma

Canadian Journal of Cardiology

Volumn 28, Issue 3, 2012, Pages 397.e5-397.e7

  Szymanski, Filip M ^a   Karpinski, Grzegorz ^a   Hrynkiewicz Szymanska, Anna ^a   Filipiak, Krzysztof J ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMLODIPINE; CATECHOLAMINE; DOXAZOSIN; HYDROCHLOROTHIAZIDE; NEBIVOLOL; NORADRENALIN; RAMIPRIL;

ADRENALECTOMY; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HUMAN; LAPAROSCOPIC SURGERY; MALE; NIGHT SWEAT; OBESITY; PHEOCHROMOCYTOMA; POLYSOMNOGRAPHY; POSITRON EMISSION TOMOGRAPHY; RESISTANT HYPERTENSION; SLEEP APNEA SYNDROME; THORAX PAIN; URINALYSIS; WEAKNESS;

EID: 84860916012     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2011.11.018     Document Type: Article

References (4)

1. Logan A.G., Perlikowski S.M., Mente A., et al. High prevalence of unrecognized sleep apnea in drug-resistant hypertension. J Hypertens 2001, 19:2271-2277.
2. Rabi D.M., Daskalopoulou S.S., Padwal R.S., et al. The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 2011, 27:415-433.
3. Parati G., Ongaro G., Bonsignore M.R., et al. Sleep apnoea and hypertension. Curr Opin Nephrol Hypertens 2002, 11:201-214.
4. Mancia G., De Backer G., Dominiczak A., et al. Guidelines for the management of arterial hypertension. Eur Heart J 2007, 28:1462-1536.